Drug intelligence / Profile preview

Autologous iPSC-derived RPE (Beijing Tongren Hospital)

Development stage: Unknown
Lead developer: Beijing Tongren Hospital
Modality: iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
Administration: Ophthalmic

Overview

Autologous iPSC-derived RPE is an experimental cell therapy developed by Beijing Tongren Hospital for the treatment of refractory age-related macular degeneration (AMD). The therapy involves generating induced pluripotent stem cells (iPSCs) from a patient's own somatic cells, which are then differentiated into clinical-grade retinal pigment epithelium (RPE) cells. These autologous RPE cells are surgically transplanted into the subretinal space to replace damaged or lost native RPE cells. By restoring the RPE layer, the therapy aims to provide essential metabolic and structural support to photoreceptors, potentially halting or reversing vision loss in patients with advanced AMD.

Other names: Autologous iPSC-RPEiPSC-derived RPE

Beyond the preview

Go deeper on Autologous iPSC-derived RPE (Beijing Tongren Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autologous iPSC-derived RPE (Beijing Tongren Hospital).

Explore the full profile